© 2020 RSM US LLP. All rights reserved.
Health Care merger and acquisition trends
Stay up to speed on the latest health care deal insights
Many of the drivers that propelled a robust mergers and acquisitions (M&A) cycle in the health care industry over the last 12 months remain intact. Aging populations, the evolving regulatory environment, expiring intellectual property, technical advances across both hardware and software, consumerism, digital health, and many other factors are still in play, and the environment has become more complex throughout the last several years.
Another complicating factor—largely positive—is the uptick in investment by both private equity (PE) funds that are relatively new to health care investment, and venture firms targeting nascent enterprises, particularly in the biotechnology space. PE is helping drive significant consolidation across regional markets and various service provider niches at the lower end of middle markets. Venture is helping bring to market an ever-proliferating array of software and hardware that will result in more efficient care delivery, therapy discovery and implementation. However, that innovation will likely contribute to potential M&A or consolidation in the future as larger companies look to derive growth and innovation from buying more innovative startups and synergies from absorbing competitors.
To learn how health care organizations can navigate the complexities of M&A read some of our recent insights.
As PE firms are increasingly investing in healthcare businesses, what are the economics of such deals on doctors? Listen and learn.
PE investors and health care entrepreneurs see an opportunity to offer behavioral health services via efficient and tech-enabled platforms.
COVID-19’s impact and deferral on nonurgent procedures are affecting health care organizations in ways few predicted.
Before investing in a health care company, private equity firms need to thoroughly understand the cybersecurity risks they may inherit.